Analyst consensus rating
Satellos Bioscience Analyst Rating: Strong Buy
MSLE is rated Strong Buy by 3 analysts with a $27.67 target. As of 2026-08-22.
Direct answer
Satellos Bioscience's consensus rating is Strong Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $27.67.
Forecast evidence checked August 22, 2026.
Get free Satellos Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $10.01
- Average price target
- $27.67
- High price target
- $40.00
- Low price target
- $20.00
- Low target gap
- +99.8%
- Target upside
- +176.4%
- High target gap
- +299.6%
- Target range width
- 199.8%
- Consensus rating
- Strong Buy
- Analysts
- 3
- Evidence date
- August 22, 2026
- Valid through
- August 29, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Satellos Bioscience?
Satellos Bioscience has a verified Strong Buy consensus. The same dataset has an average price target of $27.67.
How far are Satellos Bioscience's low and high targets from the recorded price?
The low target implies +99.8%, while the high target implies +299.6%.
How many analysts are included in Satellos Bioscience's consensus?
The verified consensus includes 3 analysts.
How is Satellos Bioscience's target upside or downside calculated?
The average target of $27.67 is divided by the recorded price of $10.01, then one is subtracted to produce +176.4%. This does not guarantee a future return.
When was Satellos Bioscience's analyst forecast verified?
The data was verified on 2026-08-22. The dataset is valid through 2026-08-29.